Achmea Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-138,375
| Closed | -$37.9M | – | 267 |
|
|
2025
Q3 | $37.9M | Sell |
138,375
-99,277
| -42% | -$27.1M | 0.47% | 47 |
|
|
2025
Q2 | $61.3M | Sell |
237,652
-145
| -0.1% | -$34.6K | 0.79% | 21 |
|
|
2025
Q1 | $53.2M | Buy |
237,797
+13,703
| +6% | +$3.2M | 0.78% | 23 |
|
|
2024
Q4 | $51.2M | Sell |
224,094
-32,668
| -13% | -$7.87M | 0.84% | 15 |
|
|
2024
Q3 | $62.7M | Buy |
256,762
+202,527
| +373% | +$45.3M | 1.03% | 12 |
|
|
2024
Q2 | $10.4M | Buy |
54,235
+50,704
| +1,436% | +$10.3M | 0.19% | 137 |
|
|
2024
Q1 | $699K | Hold |
3,531
| – | – | 0.01% | 390 |
|
|
2023
Q4 | $608K | Hold |
3,531
| – | – | 0.01% | 436 |
|
|
2023
Q3 | $522K | Sell |
3,531
-544
| -13% | -$98.4K | 0.01% | 442 |
|
|
2023
Q2 | $890K | Buy |
4,075
+1,760
| +76% | +$392K | 0.02% | 442 |
|
|
2023
Q1 | $507K | Sell |
2,315
-161,985
| -99% | -$35.1M | 0.01% | 461 |
|
|
2022
Q4 | $32M | Buy |
164,300
+2,210
| +1% | +$486K | 1.07% | 16 |
|
|
2022
Q3 | $35.4M | Sell |
162,090
-18,943
| -10% | -$4.31M | 1.25% | 9 |
|
|
2022
Q2 | $38M | Sell |
181,033
-4,649
| -3% | -$990K | 1.23% | 11 |
|
|
2022
Q1 | $45M | Buy |
+185,682
| New | +$44.9M | 1.17% | 11 |
|
|
2021
Q4 | – | Sell |
-57,329
| Closed | -$15.1M | – | 521 |
|
|
2021
Q3 | $15.1M | Buy |
57,329
+38,225
| +200% | +$10.5M | 0.46% | 44 |
|
|
2021
Q2 | $4.71M | Sell |
19,104
-7,608
| -28% | -$1.6M | 0.16% | 172 |
|
|
2021
Q1 | $5.18M | Sell |
26,712
-723
| -3% | -$145K | 0.18% | 157 |
|
|
2020
Q4 | $5.83M | Sell |
27,435
-4,333
| -14% | -$864K | 0.21% | 133 |
|
|
2020
Q3 | $5.45M | Buy |
+31,768
| New | +$5.87M | 0.23% | 120 |
|
|
2020
Q1 | – | Sell |
-27,884
| Closed | -$4.32M | – | 493 |
|
|
2019
Q4 | $4.32M | Sell |
27,884
-6,820
| -20% | -$983K | 0.17% | 148 |
|
|
2019
Q3 | $4.69M | Hold |
34,704
| – | – | 0.19% | 143 |
|
|
2019
Q2 | $4.24M | Sell |
34,704
-12,080
| -26% | -$1.34M | 0.16% | 158 |
|
|
2019
Q1 | $4.86M | Sell |
46,784
-7,834
| -14% | -$809K | 0.2% | 122 |
|
|
2018
Q4 | $6.22M | Buy |
54,618
+18,742
| +52% | +$2.01M | 0.29% | 85 |
|
|
2018
Q3 | $4.13M | Buy |
35,876
+1,187
| +3% | +$130K | 0.16% | 159 |
|
|
2018
Q2 | $3.59M | Buy |
34,689
+21,241
| +158% | +$2.15M | 0.13% | 205 |
|
|
2018
Q1 | $1.32M | Hold |
13,448
| – | – | 0.04% | 349 |
|
|
2017
Q4 | $1.14M | Buy |
13,448
+1,544
| +13% | +$128K | 0.04% | 367 |
|
|
2017
Q3 | $915K | Hold |
11,904
| – | – | 0.05% | 337 |
|
|
2017
Q2 | $926K | Buy |
11,904
+999
| +9% | +$71.5K | 0.06% | 338 |
|
|
2017
Q1 | $785K | Buy |
+10,905
| New | +$754K | 0.04% | 392 |
|
Other funds holding RMD
Achmea Investment Management's RMD Position: Q4 2025 in Review
Achmea Investment Management sold out of ResMed (RMD) in Q4 2025, closing a stake of 138,375 shares — an estimated $37.9M sold.
Achmea Investment Management first reported a position in RMD in Q1 2017 and held it in 32 quarters. The position peaked at $62.7M in Q3 2024. 945 funds tracked by Wall St. Rank hold RMD as of Q4 2025.
- Achmea Investment Management reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
- Achmea Investment Management sold 138,375 ResMed shares in Q4 2025, an estimated $37.9M.
- Achmea Investment Management first reported a position in ResMed in Q1 2017 and held it in 32 quarters.
- Achmea Investment Management's ResMed position peaked at $62.7M in Q3 2024.
- 945 funds tracked by Wall St. Rank held ResMed as of Q4 2025.
Based on Achmea Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.